Related Experiment Videos

Amphotericin B fever in rabbits

Life Sciences
|March 26, 1984
PubMed

Insights

Slow intravenous infusion of amphotericin B (amB) caused fever in rabbits, with higher doses leading to more sustained fevers. Endotoxin-tolerant rabbits showed reduced fever responses to amB, while mice did not develop fever.

Area of Science:

  • Pharmacology
  • Toxicology
  • Immunology

Background:

  • Amphotericin B (amB) is a critical antifungal agent.
  • Fever is a common side effect of intravenous drug administration.
  • Understanding pyrogenic responses to amB is crucial for patient safety.

Purpose of the Study:

  • To investigate the pyrogenic effects of amphotericin B (amB) in rabbits.
  • To compare fever induction by slow infusion versus bolus injection of amB.
  • To determine the threshold pyrogenic dose of amB in rabbits.

Main Methods:

  • Intravenous administration of amphotericin B (amB) to male adult rabbits via slow infusion and bolus injection.
  • Dose-ranging studies to identify pyrogenic thresholds.
  • Assessment of rectal temperature changes.
  • Evaluation of amB pyrogenicity in endotoxin-tolerant rabbits and mice.

Main Results:

  • Slow intravenous infusion of amB induced a moderate, dose-dependent fever in rabbits.
  • Bolus injection of amB was less pyrogenic, requiring higher doses for fever induction.
  • The threshold pyrogenic dose of amB was approximately 0.16 mg/kg.
  • Endotoxin-tolerant rabbits exhibited a blunted febrile response to amB.
  • No fever was observed in mice treated with amB.

Conclusions:

  • The route and rate of amphotericin B administration significantly influence its pyrogenic potential in rabbits.
  • Fever response to amB is dose-dependent and can be modulated by endotoxin tolerance.
  • Amphotericin B does not appear to be pyrogenic in mice.

Related Concept Videos